S. P. Epstein

690 total citations
8 papers, 201 citations indexed

About

S. P. Epstein is a scholar working on Ophthalmology, Public Health, Environmental and Occupational Health and Epidemiology. According to data from OpenAlex, S. P. Epstein has authored 8 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Ophthalmology, 3 papers in Public Health, Environmental and Occupational Health and 2 papers in Epidemiology. Recurrent topics in S. P. Epstein's work include Ocular Surface and Contact Lens (3 papers), Herpesvirus Infections and Treatments (2 papers) and Corneal Surgery and Treatments (2 papers). S. P. Epstein is often cited by papers focused on Ocular Surface and Contact Lens (3 papers), Herpesvirus Infections and Treatments (2 papers) and Corneal Surgery and Treatments (2 papers). S. P. Epstein collaborates with scholars based in United States, Netherlands and Belgium. S. P. Epstein's co-authors include Marjolein Visser, Steven Boonen, Eric Orwoll, Bruce Mitlak, Yves Rolland, Kieran F. Reid, Cyrus Cooper, Y Tsouderos, Jean‐Yves Reginster and Avan Aihie Sayer and has published in prestigious journals such as Investigative Ophthalmology & Visual Science, Calcified Tissue International and PubMed.

In The Last Decade

S. P. Epstein

8 papers receiving 198 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. P. Epstein United States 3 163 45 22 22 20 8 201
Ryan Cvejkus United States 8 114 0.7× 22 0.5× 22 1.0× 18 0.8× 10 0.5× 23 196
Suk-Kyoon Song South Korea 6 155 1.0× 28 0.6× 64 2.9× 17 0.8× 18 0.9× 17 291
Ionela Pașcanu Romania 8 63 0.4× 27 0.6× 34 1.5× 43 2.0× 28 1.4× 36 206
Qiongying Deng China 10 78 0.5× 6 0.1× 20 0.9× 17 0.8× 6 0.3× 15 196
Flávia Neves Bueloni-Dias Brazil 9 88 0.5× 4 0.1× 20 0.9× 65 3.0× 64 3.2× 21 327
Siyu Dai China 7 54 0.3× 6 0.1× 32 1.5× 18 0.8× 7 0.3× 27 128
Marco Arreghini Italy 9 41 0.3× 4 0.1× 5 0.2× 9 0.4× 11 0.6× 15 252
Suvajit Samanta United States 5 33 0.2× 4 0.1× 17 0.8× 4 0.2× 34 1.7× 6 195
Katrin Esefeld Germany 9 99 0.6× 8 0.2× 41 1.9× 16 0.7× 1 0.1× 34 253
Alexandros Mitropoulos United Kingdom 7 34 0.2× 4 0.1× 40 1.8× 6 0.3× 9 0.5× 18 193

Countries citing papers authored by S. P. Epstein

Since Specialization
Citations

This map shows the geographic impact of S. P. Epstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. P. Epstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. P. Epstein more than expected).

Fields of papers citing papers by S. P. Epstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. P. Epstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. P. Epstein. The network helps show where S. P. Epstein may publish in the future.

Co-authorship network of co-authors of S. P. Epstein

This figure shows the co-authorship network connecting the top 25 collaborators of S. P. Epstein. A scholar is included among the top collaborators of S. P. Epstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. P. Epstein. S. P. Epstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cooper, Cyrus, Roger A. Fielding, Marjolein Visser, et al.. (2013). Tools in the Assessment of Sarcopenia. Calcified Tissue International. 93(3). 201–210. 184 indexed citations
2.
Epstein, S. P., Yi Wei, & Penny A. Asbell. (2009). Toxicity of Low-Concentration Benzalkonium Chloride on the Ocular Surface (Corneal and Conjunctival Epithelium). Investigative Ophthalmology & Visual Science. 50(13). 5525–5525. 2 indexed citations
3.
Massingale, M. L., S. P. Epstein, M. Vallabhajosyula, et al.. (2009). Dry Eye Disease: Correlating HLA-DR Expression with Clinical Severity. Investigative Ophthalmology & Visual Science. 50(13). 4664–4664. 1 indexed citations
4.
Epstein, S. P. & Penny A. Asbell. (2007). The Effect of Travoprost Z, Latanoprost and Their Individual Components on the Ocular Surface (Corneal and Conjunctival Epithelium).. Investigative Ophthalmology & Visual Science. 48(13). 4813–4813. 1 indexed citations
5.
Epstein, S. P., et al.. (2006). Toxicity of Ocular Preservatives and Buffering Agents on the Ocular Surface (Corneal and Conjunctival Epithelium). Investigative Ophthalmology & Visual Science. 47(13). 4961–4961. 2 indexed citations
6.
Epstein, S. P., et al.. (2003). Topical Cobalt Chelate Ctc-96 for Treatment of Adenovirus Conjunctivitis in a Rabbit Model. Investigative Ophthalmology & Visual Science. 44(13). 4650–4650. 2 indexed citations
7.
Epstein, S. P., et al.. (2001). Recurrent ocular herpes simplex keratitis following excimer laser photorefractive keratectomy in a rabbit model.. PubMed. 27(2). 94–9. 6 indexed citations
8.
Epstein, S. P.. (1974). Mithramycin in Paget's disease.. PubMed. 48(31). 1328–30. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026